![]() |
Volumn 32, Issue 4, 2018, Pages e124-e126
|
Granuloma annulare associated with immune checkpoint inhibitors
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CHECKPOINT KINASE INHIBITOR;
DURVALUMAB;
NIVOLUMAB;
PEMBROLIZUMAB;
STEROID;
IMMUNOLOGIC FACTOR;
IMMUNOLOGICAL ANTINEOPLASTIC AGENT;
AGED;
ANORECTAL DISEASE;
CASE REPORT;
CD3+ T LYMPHOCYTE;
CLINICAL ARTICLE;
DISEASE ASSOCIATION;
DRUG RESPONSE;
FEMALE;
GRANULOMA;
GRANULOMA ANNULARE;
HISTIOCYTIC GRANULOMA;
HISTOPATHOLOGY;
HUMAN;
HUMAN CELL;
IMMUNOHISTOCHEMISTRY;
LETTER;
LYMPHOCYTIC INFILTRATION;
MALE;
MELANOMA;
METASTATIC ANORECTAL MUCOSAL MELANOMA;
MULTIPLE CYCLE TREATMENT;
NECROBIOTIC DISORDER;
PRIORITY JOURNAL;
SKIN DEFECT;
SQUAMOUS CELL CARCINOMA;
TONSIL CARCINOMA;
TRANSITIONAL CELL CARCINOMA;
CHEMICALLY INDUCED;
AGED;
ANTINEOPLASTIC AGENTS, IMMUNOLOGICAL;
FEMALE;
GRANULOMA ANNULARE;
HUMANS;
IMMUNOLOGIC FACTORS;
MALE;
NIVOLUMAB;
|
EID: 85044277696
PISSN: 09269959
EISSN: 14683083
Source Type: Journal
DOI: 10.1111/jdv.14617 Document Type: Letter |
Times cited : (20)
|
References (8)
|